Clinicopathological and Prognostic Significance of Melatonin Receptor MT1 (MTNR1A) Expression in Breast Cancer Patients: A Systematic Review Tan Deasy Tandika Wijaya1,2, Aditya Sita Sari1,3*, Fishella Aprista Rahmanti1,2 Abstract Background: Breast cancer caused 0.67 million deaths in 2022, and clinicians need tissue markers that refine risk beyond stage, hormone receptors, and